Home › Companies › CORBUS PHARMACEUTICALS HOLDINGS INC. › 2024-2025
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and CORBUS PHARMACEUTICALS HOLDINGS INC.’s Form 8-K, filed May 19, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of May 15, 2025: 9 items on CORBUS PHARMACEUTICALS HOLDINGS INC.’s Form 8-K, filed May 19, 2025: 1 approved · 8 passed (calculated).
No notable dissent.
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Proxy season: 2023-2024 2024-2025 2025-2026
Activist investors: Ra Capital Management, L.P. (13F, 9.9%, as of September 30, 2026)
Explore CORBUS PHARMACEUTICALS HOLDINGS INC. in the interactive database Compare manager voting policies
These tallies are CORBUS PHARMACEUTICALS HOLDINGS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 19, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Yuval Cohen | 6,681,546 | -- | -- | 65,244 | 2,281,655 | 99.0% | Passed (calculated) | — |
| Elect Director: Alan Holmer | 6,678,977 | -- | -- | 67,813 | 2,281,655 | 99% | Passed (calculated) | — |
| Elect Director: Rachelle Jacques | 6,634,539 | -- | -- | 112,251 | 2,281,655 | 98% | Passed (calculated) | — |
| Elect Director: John Jenkins | 6,681,768 | -- | -- | 65,022 | 2,281,655 | 99.0% | Passed (calculated) | — |
| Elect Director: Anne Altmeyer | 6,677,977 | -- | -- | 68,813 | 2,281,655 | 99% | Passed (calculated) | — |
| Elect Director: Yong Ben | 6,667,049 | -- | -- | 79,741 | 2,281,655 | 99% | Passed (calculated) | — |
| Elect Director: Winston Kung | 6,568,610 | -- | -- | 178,180 | 2,281,655 | 97% | Passed (calculated) | — |
| 2. Proposal to ratify the appointment of EisnerAmper LLP as the Company's independent registered public accounting firm for the Company's fiscal year ending December 31, 2025 | 8,841,947 | 154,305 | 32,193 | -- | -- | 98% | Approved | — |
| The votes were cast as follows with respect to the proposal to vote, on an advisory basis, on the compensation of the Company's named executive officers as described in the Company's definitive proxy statement | 6,519,904 | 215,784 | 11,102 | -- | 2,281,655 | 97% | Passed (calculated) | — |
Source: CORBUS PHARMACEUTICALS HOLDINGS INC., Form 8-K, filed with the SEC on May 19, 2025 — read the filing on EDGAR.
See voting trends for Health Care companies, 2024-2025: shareholder support by sector and by company size.
105 asset managers disclosed a vote on at least one CORBUS PHARMACEUTICALS HOLDINGS INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 3 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Prior year: 99.7% for (May 16, 2024 meeting) ▼ 0.7 pts
Description as filed by funds: Election of Directors: Alan Holmer
CORBUS PHARMACEUTICALS HOLDINGS INC.’s own tally for this item (“Elect Director: Alan Holmer”): 6,678,977 for, 67,813 withheld, per its Form 8-K filed May 19, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 31 asset managers below reported 1,063,512 for, 1,045 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 645,417 | 0 | 0 | 0 | For |
| BlackRock | 155,344 | 0 | 0 | 0 | For |
| Charles Schwab | 95,142 | 0 | 0 | 0 | For |
| Victory Capital | 33,978 | 0 | 0 | 0 | For |
| Fidelity | 27,153 | 0 | 0 | 0 | For |
| Aberdeen | 26,894 | 0 | 0 | 0 | For |
| Equitable | 16,099 | 0 | 0 | 0 | For |
| Goldman Sachs | 14,342 | 0 | 0 | 0 | For |
| Lincoln Financial | 8,100 | 0 | 0 | 0 | For |
| Northern Trust | 7,898 | 0 | 0 | 0 | For |
| Global X | 6,696 | 0 | 0 | 0 | For |
| Pacific Life | 4,740 | 0 | 0 | 0 | For |
| John Hancock | 4,203 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 3,404 | 0 | 0 | 0 | For |
| ProShares | 2,541 | 0 | 0 | 0 | For |
| Nationwide | 1,935 | 0 | 0 | 0 | For |
| DWS | 1,801 | 0 | 0 | 0 | For |
| SEI | 1,700 | 0 | 0 | 0 | For |
| Brighthouse | 1,370 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 1,291 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 0 | 996 | Withhold |
| Columbia Threadneedle | 926 | 0 | 0 | 0 | For |
| Voya | 844 | 0 | 0 | 0 | For |
| State Street | 492 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 400 | 0 | 0 | 0 | For |
Showing the 25 largest of 31 asset managers. All 31 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Prior year: 93.1% for (May 16, 2024 meeting) ▲ 5.9 pts
Description as filed by funds: Election of Directors: Anne Altmeyer
CORBUS PHARMACEUTICALS HOLDINGS INC.’s own tally for this item (“Elect Director: Anne Altmeyer”): 6,677,977 for, 68,813 withheld, per its Form 8-K filed May 19, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 31 asset managers below reported 1,064,557 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 645,417 | 0 | 0 | 0 | For |
| BlackRock | 155,344 | 0 | 0 | 0 | For |
| Charles Schwab | 95,142 | 0 | 0 | 0 | For |
| Victory Capital | 33,978 | 0 | 0 | 0 | For |
| Fidelity | 27,153 | 0 | 0 | 0 | For |
| Aberdeen | 26,894 | 0 | 0 | 0 | For |
| Equitable | 16,099 | 0 | 0 | 0 | For |
| Goldman Sachs | 14,342 | 0 | 0 | 0 | For |
| Lincoln Financial | 8,100 | 0 | 0 | 0 | For |
| Northern Trust | 7,898 | 0 | 0 | 0 | For |
| Global X | 6,696 | 0 | 0 | 0 | For |
| Pacific Life | 4,740 | 0 | 0 | 0 | For |
| John Hancock | 4,203 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 3,404 | 0 | 0 | 0 | For |
| ProShares | 2,541 | 0 | 0 | 0 | For |
| Nationwide | 1,935 | 0 | 0 | 0 | For |
| DWS | 1,801 | 0 | 0 | 0 | For |
| SEI | 1,700 | 0 | 0 | 0 | For |
| Brighthouse | 1,370 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 1,291 | 0 | 0 | 0 | For |
| Calvert | 996 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 926 | 0 | 0 | 0 | For |
| Voya | 844 | 0 | 0 | 0 | For |
| State Street | 492 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 400 | 0 | 0 | 0 | For |
Showing the 25 largest of 31 asset managers. All 31 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.0% Majority: yes · of votes cast
Prior year: 93.2% for (May 16, 2024 meeting) ▲ 5.9 pts
Description as filed by funds: Election of Directors: John Jenkins
CORBUS PHARMACEUTICALS HOLDINGS INC.’s own tally for this item (“Elect Director: John Jenkins”): 6,681,768 for, 65,022 withheld, per its Form 8-K filed May 19, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 99.0% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 31 asset managers below reported 1,064,557 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 645,417 | 0 | 0 | 0 | For |
| BlackRock | 155,344 | 0 | 0 | 0 | For |
| Charles Schwab | 95,142 | 0 | 0 | 0 | For |
| Victory Capital | 33,978 | 0 | 0 | 0 | For |
| Fidelity | 27,153 | 0 | 0 | 0 | For |
| Aberdeen | 26,894 | 0 | 0 | 0 | For |
| Equitable | 16,099 | 0 | 0 | 0 | For |
| Goldman Sachs | 14,342 | 0 | 0 | 0 | For |
| Lincoln Financial | 8,100 | 0 | 0 | 0 | For |
| Northern Trust | 7,898 | 0 | 0 | 0 | For |
| Global X | 6,696 | 0 | 0 | 0 | For |
| Pacific Life | 4,740 | 0 | 0 | 0 | For |
| John Hancock | 4,203 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 3,404 | 0 | 0 | 0 | For |
| ProShares | 2,541 | 0 | 0 | 0 | For |
| Nationwide | 1,935 | 0 | 0 | 0 | For |
| DWS | 1,801 | 0 | 0 | 0 | For |
| SEI | 1,700 | 0 | 0 | 0 | For |
| Brighthouse | 1,370 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 1,291 | 0 | 0 | 0 | For |
| Calvert | 996 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 926 | 0 | 0 | 0 | For |
| Voya | 844 | 0 | 0 | 0 | For |
| State Street | 492 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 400 | 0 | 0 | 0 | For |
Showing the 25 largest of 31 asset managers. All 31 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Prior year: 93.7% for (May 16, 2024 meeting) ▲ 4.6 pts
Description as filed by funds: Election of Directors: Rachelle Jacques
CORBUS PHARMACEUTICALS HOLDINGS INC.’s own tally for this item (“Elect Director: Rachelle Jacques”): 6,634,539 for, 112,251 withheld, per its Form 8-K filed May 19, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 31 asset managers below reported 1,063,561 for, 996 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 645,417 | 0 | 0 | 0 | For |
| BlackRock | 155,344 | 0 | 0 | 0 | For |
| Charles Schwab | 95,142 | 0 | 0 | 0 | For |
| Victory Capital | 33,978 | 0 | 0 | 0 | For |
| Fidelity | 27,153 | 0 | 0 | 0 | For |
| Aberdeen | 26,894 | 0 | 0 | 0 | For |
| Equitable | 16,099 | 0 | 0 | 0 | For |
| Goldman Sachs | 14,342 | 0 | 0 | 0 | For |
| Lincoln Financial | 8,100 | 0 | 0 | 0 | For |
| Northern Trust | 7,898 | 0 | 0 | 0 | For |
| Global X | 6,696 | 0 | 0 | 0 | For |
| Pacific Life | 4,740 | 0 | 0 | 0 | For |
| John Hancock | 4,203 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 3,404 | 0 | 0 | 0 | For |
| ProShares | 2,541 | 0 | 0 | 0 | For |
| Nationwide | 1,935 | 0 | 0 | 0 | For |
| DWS | 1,801 | 0 | 0 | 0 | For |
| SEI | 1,700 | 0 | 0 | 0 | For |
| Brighthouse | 1,370 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 1,291 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 0 | 996 | Withhold |
| Columbia Threadneedle | 926 | 0 | 0 | 0 | For |
| Voya | 844 | 0 | 0 | 0 | For |
| State Street | 492 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 400 | 0 | 0 | 0 | For |
Showing the 25 largest of 31 asset managers. All 31 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Winston Kung
CORBUS PHARMACEUTICALS HOLDINGS INC.’s own tally for this item (“Elect Director: Winston Kung”): 6,568,610 for, 178,180 withheld, per its Form 8-K filed May 19, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 31 asset managers below reported 961,019 for, 103,538 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 645,417 | 0 | 0 | 0 | For |
| BlackRock | 155,344 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 0 | 95,142 | Withhold |
| Victory Capital | 33,978 | 0 | 0 | 0 | For |
| Fidelity | 27,153 | 0 | 0 | 0 | For |
| Aberdeen | 26,894 | 0 | 0 | 0 | For |
| Equitable | 16,099 | 0 | 0 | 0 | For |
| Goldman Sachs | 14,342 | 0 | 0 | 0 | For |
| Lincoln Financial | 8,100 | 0 | 0 | 0 | For |
| Northern Trust | 7,898 | 0 | 0 | 0 | For |
| Global X | 0 | 0 | 0 | 6,696 | Withhold |
| Pacific Life | 4,740 | 0 | 0 | 0 | For |
| John Hancock | 4,203 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 3,404 | 0 | 0 | 0 | For |
| ProShares | 2,541 | 0 | 0 | 0 | For |
| Nationwide | 1,935 | 0 | 0 | 0 | For |
| DWS | 1,801 | 0 | 0 | 0 | For |
| SEI | 0 | 0 | 0 | 1,700 | Withhold |
| Brighthouse | 1,370 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 1,291 | 0 | 0 | 0 | For |
| Calvert | 996 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 926 | 0 | 0 | 0 | For |
| Voya | 844 | 0 | 0 | 0 | For |
| State Street | 492 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 400 | 0 | 0 | 0 | For |
Showing the 25 largest of 31 asset managers. All 31 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Prior year: 99.7% for (May 16, 2024 meeting) ▼ 0.9 pts
Description as filed by funds: Election of Directors: Yong Ben
CORBUS PHARMACEUTICALS HOLDINGS INC.’s own tally for this item (“Elect Director: Yong Ben”): 6,667,049 for, 79,741 withheld, per its Form 8-K filed May 19, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 31 asset managers below reported 1,064,557 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 645,417 | 0 | 0 | 0 | For |
| BlackRock | 155,344 | 0 | 0 | 0 | For |
| Charles Schwab | 95,142 | 0 | 0 | 0 | For |
| Victory Capital | 33,978 | 0 | 0 | 0 | For |
| Fidelity | 27,153 | 0 | 0 | 0 | For |
| Aberdeen | 26,894 | 0 | 0 | 0 | For |
| Equitable | 16,099 | 0 | 0 | 0 | For |
| Goldman Sachs | 14,342 | 0 | 0 | 0 | For |
| Lincoln Financial | 8,100 | 0 | 0 | 0 | For |
| Northern Trust | 7,898 | 0 | 0 | 0 | For |
| Global X | 6,696 | 0 | 0 | 0 | For |
| Pacific Life | 4,740 | 0 | 0 | 0 | For |
| John Hancock | 4,203 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 3,404 | 0 | 0 | 0 | For |
| ProShares | 2,541 | 0 | 0 | 0 | For |
| Nationwide | 1,935 | 0 | 0 | 0 | For |
| DWS | 1,801 | 0 | 0 | 0 | For |
| SEI | 1,700 | 0 | 0 | 0 | For |
| Brighthouse | 1,370 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 1,291 | 0 | 0 | 0 | For |
| Calvert | 996 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 926 | 0 | 0 | 0 | For |
| Voya | 844 | 0 | 0 | 0 | For |
| State Street | 492 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 400 | 0 | 0 | 0 | For |
Showing the 25 largest of 31 asset managers. All 31 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.0% Majority: yes · of votes cast
Prior year: 99.7% for (May 16, 2024 meeting) ▼ 0.7 pts
Description as filed by funds: Election of Directors: Yuval Cohen
CORBUS PHARMACEUTICALS HOLDINGS INC.’s own tally for this item (“Elect Director: Yuval Cohen”): 6,681,546 for, 65,244 withheld, per its Form 8-K filed May 19, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 99.0% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 31 asset managers below reported 1,064,557 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 645,417 | 0 | 0 | 0 | For |
| BlackRock | 155,344 | 0 | 0 | 0 | For |
| Charles Schwab | 95,142 | 0 | 0 | 0 | For |
| Victory Capital | 33,978 | 0 | 0 | 0 | For |
| Fidelity | 27,153 | 0 | 0 | 0 | For |
| Aberdeen | 26,894 | 0 | 0 | 0 | For |
| Equitable | 16,099 | 0 | 0 | 0 | For |
| Goldman Sachs | 14,342 | 0 | 0 | 0 | For |
| Lincoln Financial | 8,100 | 0 | 0 | 0 | For |
| Northern Trust | 7,898 | 0 | 0 | 0 | For |
| Global X | 6,696 | 0 | 0 | 0 | For |
| Pacific Life | 4,740 | 0 | 0 | 0 | For |
| John Hancock | 4,203 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 3,404 | 0 | 0 | 0 | For |
| ProShares | 2,541 | 0 | 0 | 0 | For |
| Nationwide | 1,935 | 0 | 0 | 0 | For |
| DWS | 1,801 | 0 | 0 | 0 | For |
| SEI | 1,700 | 0 | 0 | 0 | For |
| Brighthouse | 1,370 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 1,291 | 0 | 0 | 0 | For |
| Calvert | 996 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 926 | 0 | 0 | 0 | For |
| Voya | 844 | 0 | 0 | 0 | For |
| State Street | 492 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 400 | 0 | 0 | 0 | For |
Showing the 25 largest of 31 asset managers. All 31 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Prior year: 99.3% for (May 16, 2024 meeting) ▼ 2.5 pts
Description as filed by funds: APPROVAL, ON AN ADVISORY BASIS, OF THE EXECUTIVE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.
CORBUS PHARMACEUTICALS HOLDINGS INC.’s own tally for this item (“Proposal 3: The votes were cast as follows with respect to the proposal to vote, on an advisory basis, on the compensation of the Company's named executive officers as described in the Company's definitive proxy statemen”): 6,519,904 for, 215,784 against, per its Form 8-K filed May 19, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 645,417 | 0 | 0 | 0 | For |
| BlackRock | 155,344 | 0 | 0 | 0 | For |
| Charles Schwab | 95,142 | 0 | 0 | 0 | For |
| Victory Capital | 33,978 | 0 | 0 | 0 | For |
| Fidelity | 27,153 | 0 | 0 | 0 | For |
| Aberdeen | 0 | 26,894 | 0 | 0 | Against |
| Equitable | 6,179 | 9,920 | 0 | 0 | Mixed |
| Goldman Sachs | 0 | 14,342 | 0 | 0 | Against |
| Lincoln Financial | 8,100 | 0 | 0 | 0 | For |
| Northern Trust | 7,898 | 0 | 0 | 0 | For |
| Global X | 6,696 | 0 | 0 | 0 | For |
| Pacific Life | 4,740 | 0 | 0 | 0 | For |
| John Hancock | 4,203 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 3,404 | 0 | 0 | 0 | For |
| ProShares | 2,541 | 0 | 0 | 0 | For |
| Nationwide | 1,935 | 0 | 0 | 0 | For |
| DWS | 1,801 | 0 | 0 | 0 | For |
| SEI | 1,700 | 0 | 0 | 0 | For |
| Brighthouse | 1,370 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 1,291 | 0 | 0 | 0 | For |
| Calvert | 0 | 996 | 0 | 0 | Against |
| Columbia Threadneedle | 926 | 0 | 0 | 0 | For |
| Voya | 844 | 0 | 0 | 0 | For |
| State Street | 492 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 400 | 0 | 0 | 0 | For |
Fund voting reports, all 31 managers: 1,012,405 for, 52,152 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Octagon Capital Advisors LP | 1,115,000 | 0 | 0 | 0 | For |
| Cormorant Asset Management, LP | 1,112,072 | 0 | 0 | 0 | For |
| ORBIMED ADVISORS LLC | 849,387 | 0 | 0 | 0 | For |
| BlackRock | 262,741 | 0 | 0 | 0 | For |
| ARMISTICE CAPITAL, LLC | 236,000 | 0 | 0 | 0 | For |
| Exome Asset Management LLC | 188,100 | 0 | 0 | 0 | For |
| Global X | 148,245 | 0 | 0 | 0 | For |
| Prosight Management, LP | 113,850 | 0 | 0 | 0 | For |
| Charles Schwab | 95,144 | 0 | 0 | 0 | For |
| State Street | 93,063 | 12 | 0 | 0 | For |
| HighVista Strategies LLC | 75,292 | 0 | 0 | 0 | For |
| Vivo Capital, LLC | 75,153 | 0 | 0 | 0 | For |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 50,000 | 0 | 0 | 0 | For |
| Citadel | 45,103 | 0 | 0 | 0 | For |
| Northern Trust | 42,514 | 0 | 0 | 0 | For |
| Victory Capital | 37,668 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 35,748 | 0 | 0 | 0 | For |
| Two Sigma | 34,559 | 0 | 0 | 0 | For |
| Stonepine Capital Management, LLC | 30,000 | 0 | 0 | 0 | For |
| Aberdeen | 0 | 26,894 | 0 | 0 | Against |
| AQR | 25,990 | 0 | 0 | 0 | For |
| Vanguard | 19,777 | 0 | 0 | 0 | For |
| Nuveen | 17,871 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 0 | 15,370 | 0 | 0 | Against |
| AllianceBernstein | 0 | 10,033 | 0 | 0 | Against |
Institutional-manager reports, all 88 managers: 4,774,547 for, 74,760 against. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
98% Approved · of votes cast
Prior year: 98.1% for (May 16, 2024 meeting) ▲ 0.2 pts
Description as filed by funds: Ratification of EisnerAmper LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025.
CORBUS PHARMACEUTICALS HOLDINGS INC.’s own tally for this item (“2. Proposal to ratify the appointment of EisnerAmper LLP as the Company's independent registered public accounting firm for the Company's fiscal year ending December 31, 2025”): 8,841,947 for, 154,305 against — passed, per its Form 8-K filed May 19, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The proposal to ratify the appointment of EisnerAmper LLP as the Company's independent registered public accounting firm for the Company's fiscal year ending December 31, 2025, was approved based upon the following votes:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 31 asset managers below reported 1,064,557 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 645,417 | 0 | 0 | 0 | For |
| BlackRock | 155,344 | 0 | 0 | 0 | For |
| Charles Schwab | 95,142 | 0 | 0 | 0 | For |
| Victory Capital | 33,978 | 0 | 0 | 0 | For |
| Fidelity | 27,153 | 0 | 0 | 0 | For |
| Aberdeen | 26,894 | 0 | 0 | 0 | For |
| Equitable | 16,099 | 0 | 0 | 0 | For |
| Goldman Sachs | 14,342 | 0 | 0 | 0 | For |
| Lincoln Financial | 8,100 | 0 | 0 | 0 | For |
| Northern Trust | 7,898 | 0 | 0 | 0 | For |
| Global X | 6,696 | 0 | 0 | 0 | For |
| Pacific Life | 4,740 | 0 | 0 | 0 | For |
| John Hancock | 4,203 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 3,404 | 0 | 0 | 0 | For |
| ProShares | 2,541 | 0 | 0 | 0 | For |
| Nationwide | 1,935 | 0 | 0 | 0 | For |
| DWS | 1,801 | 0 | 0 | 0 | For |
| SEI | 1,700 | 0 | 0 | 0 | For |
| Brighthouse | 1,370 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 1,291 | 0 | 0 | 0 | For |
| Calvert | 996 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 926 | 0 | 0 | 0 | For |
| Voya | 844 | 0 | 0 | 0 | For |
| State Street | 492 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 400 | 0 | 0 | 0 | For |
Showing the 25 largest of 31 asset managers. All 31 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 12,236,767 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 5.27% |
| 2 | BlackRock | 1.27% |
| 3 | Charles Schwab | 0.78% |
| 4 | Victory Capital | 0.28% |
| 5 | Fidelity | 0.22% |
| 6 | Aberdeen | 0.22% |
| 7 | Equitable | 0.13% |
| 8 | Goldman Sachs | 0.12% |
| 9 | Lincoln Financial | 0.07% |
| 10 | Northern Trust | 0.06% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Octagon Capital Advisors LP | 9.11% |
| 2 | Cormorant Asset Management, LP | 9.09% |
| 3 | ORBIMED ADVISORS LLC | 6.94% |
| 4 | BlackRock | 2.15% |
| 5 | ARMISTICE CAPITAL, LLC | 1.93% |
| 6 | Exome Asset Management LLC | 1.54% |
| 7 | Global X | 1.21% |
| 8 | Prosight Management, LP | 0.93% |
| 9 | Charles Schwab | 0.78% |
| 10 | State Street | 0.76% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Cormorant Global Healthcare Master Fund, LP | 2,375,000 | 19.41% | Proxy statement (DEF 14A), proxy filed April 1, 2025 |
| Aberdeen Group plc | 1,321,750 | 10.80% | Schedule 13G, filed January 16, 2026 |
| OrbiMed Capital LLC | 1,172,287 | 9.58% | Proxy statement (DEF 14A), proxy filed April 1, 2025 |
| Octagon Capital Advisors LP | 1,115,000 | 9.11% | Proxy statement (DEF 14A), proxy filed April 1, 2025 |
| Kenneth Griffin | 980,610 | 8.01% | Schedule 13G, filed November 12, 2025 |
| BlackRock | 846,062 | 6.91% | Form 13F, quarter ended March 31, 2025 |
| Vanguard Group | 672,057 | 5.49% | Form 13F, quarter ended March 31, 2025 |
| Renaissance Technologies | 345,200 | 2.82% | Form 13F, quarter ended March 31, 2025 |
| Yuval Cohen | 233,936 | 1.91% | Proxy statement (DEF 14A), proxy filed April 1, 2025 |
| State Street | 223,470 | 1.83% | Form 13F, quarter ended March 31, 2025 |
Percentages above are of 12,236,767 shares outstanding, as reported by CORBUS PHARMACEUTICALS HOLDINGS INC. on its Form 10-Q dated May 2, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At CORBUS PHARMACEUTICALS HOLDINGS INC.'s shareholder meeting held May 15, 2025, in the 2024-2025 proxy season, 105 asset managers reported votes on at least one of its 9 ballot items in their SEC Form N-PX filings, covering 906 separate fund positions. On the most widely held item on that ballot — APPROVAL, ON AN ADVISORY BASIS, OF THE EXECUTIVE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE… — FOR was 97% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: CORBUS PHARMACEUTICALS HOLDINGS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 19, 2025.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from CORBUS PHARMACEUTICALS HOLDINGS INC.’s 10-Q dated May 2, 2025. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
CORBUS PHARMACEUTICALS HOLDINGS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
Proxy Votes Now, “CORBUS PHARMACEUTICALS HOLDINGS (CRBP) 2025 Annual Meeting”, https://proxyvotesnow.com/company/corbus-pharmaceuticals-holdings-inc/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.